Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06358573
Title Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Acronym INVINCIBLE-4-SAKK
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Swiss Group for Clinical Cancer Research
Indications
Therapies
Age Groups: senior | adult
Covered Countries CHE

Facility Status City State Zip Country Details
Tumor Zentrum Aarau RECRUITING Aarau 5000 Switzerland Details
St. Claraspital RECRUITING Basel 4058 Switzerland Details
Istituto Oncologico della Svizzera Italiana (IOSI) RECRUITING Bellinzona 6500 Switzerland Details
Kantonsspital Graubünden RECRUITING Chur 7000 Switzerland Details
Kantonsspital Baselland RECRUITING Liestal 4410 Switzerland Details
Kantonsspital St. Gallen RECRUITING St. Gallen 9007 Switzerland Details
TBZO - Tumor- & Brustzentrum Ostschweiz RECRUITING St. Gallen 9016 Switzerland Details
Kantonsspital Winterthur RECRUITING Winterthur 8401 Switzerland Details
Universitätsspital Zürich - Klinik für Gynäkologie RECRUITING Zürich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field